GlassScriptPhysician profile
Emily Spackman Andersen
NPI 1134618119
$4,010.57
in general payments reported to CMS, 2019-2025
12 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $2,040 · 2024: $580 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,944.05 | 2022 | |
| Abbvie INC. | $584.20 | 2024-2025 | |
| Integra Lifesciences Corporation | $295.70 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $249.92 | 2025 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Baxter Healthcare | $200.63 | 2025 | |
| Innovation Technologies INC | $139.56 | 2025 | Irrisept |
| Axogen | $126.63 | 2025 | |
| Ethicon US, LLC | $116.42 | 2024 | Vistaseal, Dermabond, Surgicel Nu-Knit |
| Kuros Biosciences USA, INC | $109.54 | 2025 | Magnetos |
| Allergan, INC. | $95.75 | 2022 | |
| Avita Medical Americas, LLC | $92.69 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $55.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.